Understanding how glyoxalase-1 is regulated in the body
Exploring regulatory mechanisms of glyoxalase-1
['FUNDING_R21'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-10828440
This study is looking at how a protein called glyoxalase-1 helps protect our cells from a harmful substance that can cause damage, especially as we age or if we're dealing with obesity, to find ways to improve health and reduce risks of age-related diseases.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-10828440 on ClinicalTrials.gov |
What this research studies
This research investigates the role of glyoxalase-1 (GLO1) in detoxifying methylglyoxal, a harmful compound that can lead to cellular damage and age-related diseases. By studying how GLO1 is regulated in skeletal muscle tissue, the research aims to uncover the mechanisms that affect its stability and activity, particularly in the context of obesity and aging. The approach includes developing advanced models to simulate and analyze the effects of reduced GLO1 levels on cellular function and metabolism. This could provide insights into how to mitigate the negative impacts of dicarbonyl stress on health.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old, particularly those experiencing obesity or age-related metabolic issues.
Not a fit: Patients who are under 21 years old or do not have metabolic conditions related to aging may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating age-related diseases and metabolic disorders.
How similar studies have performed: Previous research has shown that understanding the regulation of metabolic enzymes like GLO1 can lead to significant advancements in treating metabolic disorders, indicating that this approach has potential for success.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HAUS, JACOB M — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: HAUS, JACOB M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.